BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 24023341)

  • 1. Pancreatic neuroendocrine tumor with ectopic adrenocorticotropin production: a case report and review of literature.
    Patel FB; Khagi S; Daly KP; Lechan RM; Ummaritchot V; Saif MW
    Anticancer Res; 2013 Sep; 33(9):4001-5. PubMed ID: 24023341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic neuroendocrine tumor with ectopic adrenocorticotropin production upon second recurrence.
    Miehle K; Tannapfel A; Lamesch P; Borte G; Schenker E; Kluge R; Ott RA; Wiechmann V; Koch M; Kassahun W; Paschke R; Koch CA
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3731-6. PubMed ID: 15292297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic Pancreatic Neuroendocrine Tumor that Progressed to Ectopic Adrenocorticotropic Hormone (ACTH) Syndrome with Growth Hormone-releasing Hormone (GHRH) Production.
    Tadokoro R; Sato S; Otsuka F; Ueno M; Ohkawa S; Katakami H; Taniyama M; Nagasaka S
    Intern Med; 2016; 55(20):2979-2983. PubMed ID: 27746436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ectopic Corticotropin-Producing Neuroendocrine Tumor of the Pancreas Treated With 177Lu DOTATATE Induction and Maintenance Peptide Receptor Radionuclide Therapy.
    Makis W; McCann K; Riauka TA; McEwan AJ
    Clin Nucl Med; 2016 Jan; 41(1):50-2. PubMed ID: 26359569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An uncommon cause of Cushing's syndrome in a 70-year-old man.
    Cheung KK; So WY; Kong AP; Ma RC; Lee KF; Chow FC
    Hong Kong Med J; 2014 Aug; 20(4):335-8. PubMed ID: 25104006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single-centre experience with octreotide in the treatment of different hypersecretory syndromes in patients with functional gastroenteropancreatic neuroendocrine tumors.
    Berković MC; Altabas V; Herman D; Hrabar D; Goldoni V; Vizner B; Zjacić-Rotkvić V
    Coll Antropol; 2007 Jun; 31(2):531-4. PubMed ID: 17847934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parathyroid hormone-related peptide (PTHrP) secretion by gastroenteropancreatic neuroendocrine tumors (GEP-NETs): clinical features, diagnosis, management, and follow-up.
    Kamp K; Feelders RA; van Adrichem RC; de Rijke YB; van Nederveen FH; Kwekkeboom DJ; de Herder WW
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3060-9. PubMed ID: 24905065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis of pancreatic neuroendocrine tumor and medical treatment of endocrine symptoms].
    Takano K
    Nihon Rinsho; 2015 Mar; 73 Suppl 3():363-7. PubMed ID: 25857049
    [No Abstract]   [Full Text] [Related]  

  • 9. Ectopic Cushing's syndrome caused by a well differentiated ACTH-secreting neuroendocrine carcinoma of the ileum.
    Singer J; Werner F; Koch CA; Bartels M; Aigner T; Lincke T; Fasshauer M; Paschke R
    Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):524-9. PubMed ID: 20162505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine tumor in liver with positive ACTH receptor: a case report.
    El Zein M; Vali R; Charron M; Manson D; Perlman K; Shammas A
    J Pediatr Hematol Oncol; 2014 Jan; 36(1):e1-4. PubMed ID: 23528909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of ectopic adrenocorticotropic hormone-producing pancreatic neuroendocrine tumor with multiple liver metastases.
    Kondo T; Matsuyama R; Ashihara H; Matsuo Y; Sasaki K; Goto R; Ono K; Takaki Y; Honda Y; Iyama K; Kawashima J; Motoshima H; Tsuruzoe K; Miyamura N; Araki E
    Endocr J; 2010; 57(3):229-36. PubMed ID: 20032567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of clinicopathologic factors in 122 patients with resected pancreatic and ileal neuroendocrine tumors from a single institution.
    Dahdaleh FS; Calva-Cerqueira D; Carr JC; Liao J; Mezhir JJ; O'Dorisio TM; Howe JR
    Ann Surg Oncol; 2012 Mar; 19(3):966-72. PubMed ID: 21845496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sporadically occurring functional pancreatic endocrine tumors: review of recent literature.
    Goldin SB; Aston J; Wahi MM
    Curr Opin Oncol; 2008 Jan; 20(1):25-33. PubMed ID: 18043253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two cases of pancreatic neuroendocrine tumors with ectopic ACTH syndrome during their disease course.
    Murakami M; Hirahata K; Fujimori N; Yamamoto T; Oda Y; Kozono S; Ueda K; Ito T; Nakamura M; Ogawa Y
    Clin J Gastroenterol; 2024 Apr; 17(2):363-370. PubMed ID: 38244178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin analog octreotide LAR in gastro-entero-pancreatic tumors.
    Oberg K
    Expert Rev Anticancer Ther; 2009 May; 9(5):557-66. PubMed ID: 19445573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of two patients with metastatic neuroendocrine tumours treated with octreotide.
    van de Loosdrecht AA; van Bodegraven AA; Sepers JM; Sindram JW
    Neth J Med; 1998 Sep; 53(3):118-23. PubMed ID: 9803143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypokalemic rhabdomyolysis without watery diarrhea: an unexpected presentation of a pancreatic neuro-endocrine tumor.
    Rossi V; Saibeni S; Sinigaglia L; Peracchi M; Parafioriti A; Vecchi M
    Am J Gastroenterol; 2006 Mar; 101(3):669-72. PubMed ID: 16464230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumors.
    Lawrence B; Gustafsson BI; Kidd M; Pavel M; Svejda B; Modlin IM
    Endocrinol Metab Clin North Am; 2011 Mar; 40(1):111-34, viii. PubMed ID: 21349414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear survivin is a powerful novel prognostic marker in gastroenteropancreatic neuroendocrine tumor disease.
    Grabowski P; Griss S; Arnold CN; Hörsch D; Göke R; Arnold R; Heine B; Stein H; Zeitz M; Scherübl H
    Neuroendocrinology; 2005; 81(1):1-9. PubMed ID: 15809513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ectopic Cushing's syndrome due to concurrent corticotropin-releasing hormone (CRH) and adrenocorticotropic hormone (ACTH) secreted by malignant gastrinoma.
    Park SY; Rhee Y; Youn JC; Park YN; Lee S; Kim DM; Song SY; Lim SK
    Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):13-6. PubMed ID: 17286228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.